Curcumin modulates the apolipoprotein B mRNA editing by coordinating the expression of cytidine deamination to uridine editosome components in primary mouse hepatocytes
10.4196/kjpp.2019.23.3.181
- Author:
Pan HE
1
;
Nan TIAN
Author Information
1. Institute of Molecular Medicine, Life Science College, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China. tiannanlux@126.com
- Publication Type:Original Article
- Keywords:
APOBEC-1;
Curcumin;
Hepatocytes;
RNA editing
- MeSH:
Animals;
Apolipoproteins B;
Apolipoproteins;
Atherosclerosis;
Complement System Proteins;
Curcuma;
Curcumin;
Cytidine;
Deamination;
Hepatocytes;
Lipoproteins, LDL;
Mice;
Plasma;
Rats;
RNA Editing;
RNA, Messenger;
RNA-Binding Proteins;
Uridine
- From:The Korean Journal of Physiology and Pharmacology
2019;23(3):181-189
- CountryRepublic of Korea
- Language:English
-
Abstract:
Curcumin, an active ingredient of Curcuma longa L., can reduce the concentration of low-density lipoproteins in plasma, in different ways. We had first reported that curcumin exhibits hypocholesterolemic properties by improving the apolipoprotein B (apoB) mRNA editing in primary rat hepatocytes. However, the role of curcumin in the regulation of apoB mRNA editing is not clear. Thus, we investigated the effect of curcumin on the expression of multiple editing components of apoB mRNA cytidine deamination to uridine (C-to-U) editosome. Our results demonstrated that treatment with 50 µM curcumin markedly increased the amount of edited apoB mRNA in primary mouse hepatocytes from 5.13%–8.05% to 27.63%–35.61%, and significantly elevated the levels of the core components apoB editing catalytic polypeptide-1 (APOBEC-1), apobec-1 complementation factor (ACF), and RNA-binding-motif-protein-47 (RBM47), as well as suppressed the level of the inhibitory component glycine-arginine-tyrosine-rich RNA binding protein. Moreover, the increased apoB RNA editing by 50 µM curcumin was significantly reduced by siRNA-mediated APOBEC-1, ACF, and RBM47 knockdown. These findings suggest that curcumin modulates apoB mRNA editing by coordinating the multiple editing components of the editosome in primary hepatocytes. Our data provided evidence for curcumin to be used therapeutically to prevent atherosclerosis.
